Melanoma Symptoms and Cause

By , BPharm

The symptoms of melanoma usually present initially as changes in the appearance to the skin, which is caused be changes to the way the melanocytes are produced.


Moles normally occur on healthy skin and do not necessarily represent an early sign of melanoma. Moles are usually evenly colored and may be round or oval and flat or raised from the surface. They typically appear in childhood or adolescence and stay unchanged for many years.

The development of melanoma may be recognized by changes to the skin, particularly regarding the size, shape and color of moles. The ABCDE rule is used to guide the parameters to look for when checking for melanoma, which includes:

  • Asymmetry: uneven shape of mole or birthmark
  • Border: irregular or blurred edge of mole or birthmark
  • Color: various color shades or patches of mole or birthmark
  • Diameter: spot larger than 6mm (or ¼ inch) in diameter
  • Evolving: changes evident in size, shape or color

However, these signs do not encompass all forms of melanoma and it is important to consider abnormal changes or the appearance of new spots on the skin. In particular, changes that look different from the rest of the moles on the skin of the individual, or those occurring at an elder age, are of greater concern.

Other warning signs of melanoma include:

  • A sore that doesn’t heal as normal
  • Spread of pigment to skin surrounds spot
  • Redness or swelling around area
  • Itchiness, tenderness or pain in the area
  • Scaliness, oozing or bleeding from the spot.


There are two main causes of melanoma that have been identified to date; exposure to ultraviolet (UV) radiation from sunlight and genetic susceptibilities.

Exposure to UV radiation was suggested as a causative factor for melanoma by Henry Lancaster, who was an Australian mathematician that noted the high incidence of melanoma in Australian individuals that were exposed to significant sunlight.

This notion has since been supported by various scientific studies, including those that associated the use of tanning beds that utilized UV radiation with increased risk of melanoma. According to the International Agency for Research on Cancer, tanning beds are carcinogenic to humans and individuals that begin using them before the age of 30 face a relative risk 75% higher than other individuals to develop melanoma. Additionally, people with a workplace environment that has a high exposure to UV radiation, such as farmers and those working on airplanes, also face a higher risk than other individuals. The skin cells can absorb UVA and UVB light, which causes damages to the DNA called cyclobutane pyrimidine dimers (CPDs).

The characteristics of the individuals skin, including the color, pigmentation and age at exposure can also affect the risk of melanoma. The highest incidence is seen in populations with fair skin living in areas with high exposure to UV radiation from sunlight, such as European settlers in Australia.

There are also some specific gene mutations that are associated with an increased susceptibility for melanoma. One class of genetic mutations involves changes to the CDKN2A gene, which alters the stability of the p53 transcriptional factor and causes apoptosis related to the cancer. Individuals with a mutation in the MC1R gene have a relative risk two to four times higher than the general population to develop melanoma. This gene is very common and is present in all members of the population with red hair.

A strong family history of melanoma increases the risk of an individual to suffer from the condition, due to the possibility of a mutated gene inheritance that may increase the susceptibility to UV radiation.


Further Reading

Last Updated: Nov 12, 2015

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
You might also like... ×
New drug combination may be effective against malignant melanoma